患者报告了COVID-19患者的语音障碍和听觉感知语音评估结果。

IF 0.7 4区医学 Q4 AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY

Logopedics Phoniatrics Vocology Pub Date : 2023-07-01 DOI:10.1080/14015439.2021.2011958

Emel Tahir, Esra Kavaz, Senem Çengel Kurnaz, Fatih Temoçin, Aynur Atilla

{"title":"患者报告了COVID-19患者的语音障碍和听觉感知语音评估结果。","authors":"Emel Tahir, Esra Kavaz, Senem Çengel Kurnaz, Fatih Temoçin, Aynur Atilla","doi":"10.1080/14015439.2021.2011958","DOIUrl":null,"url":null,"abstract":"Purpose: The purpose of this study is to compare patient-reported voice handicap and auditory-perceptual measures of voice between healthy individuals and COVID-19 patients, as well as to investigate the effect of clinical factors on voice quality.Methods: COVID-19 patients (n = 138) and 90 healthy controls were included in the study. The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) was used to grade voice samples based on overall severity, roughness, breathiness, strain, pitch, and loudness. The Voice Handicap Index-10 was completed by all participants (VHI-10). Physical (pVHI), emotional (eVHI) and functional (fVHI) subscores were calculated. Clinical data were collected (disease stage, CT grade, neutrophil/lymphocyte ratio, CRP, and symptoms).Results: A statistically significant difference between patient and control groups in VHI-10 and CAPE-V scores was detected (p < 0.001). Except eVHI, total score and all subscale scores were higher in patients with COVID-19 as the pVHI was the most affected (η2 = 0.324) subscale. All scores of CAPE-V were significantly worse in patients with COVID-19 as highest impact of COVID-19 was on breathiness (η2 = 0.518). Pre-existing pulmonary comorbidity, dyspnoea and N/L was significantly associated with the VHI-10 overall score (βpc = 4.27, βdyspnoea = 5.69 and βnl = 0.25). The overall severity of CAPE-V was significantly dependent on dyspnoea and pulmonary comorbidity (βdyspnoea = 11.25, βpc = 10.12). VHI ≥4 and CAPE-V overall severity ≥11 were good indicators of COVID-19 related dysphonia.Conclusions: COVID-19 causes patient-reported voice handicap and deteriorates auditory-perceptual measures of voice. COVID-19 related voice impairment was mainly associated with the decreased respiratory capacity.","PeriodicalId":49903,"journal":{"name":"Logopedics Phoniatrics Vocology","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"Patient reported voice handicap and auditory-perceptual voice assessment outcomes in patients with COVID-19.\",\"authors\":\"Emel Tahir, Esra Kavaz, Senem Çengel Kurnaz, Fatih Temoçin, Aynur Atilla\",\"doi\":\"10.1080/14015439.2021.2011958\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: The purpose of this study is to compare patient-reported voice handicap and auditory-perceptual measures of voice between healthy individuals and COVID-19 patients, as well as to investigate the effect of clinical factors on voice quality.Methods: COVID-19 patients (n = 138) and 90 healthy controls were included in the study. The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) was used to grade voice samples based on overall severity, roughness, breathiness, strain, pitch, and loudness. The Voice Handicap Index-10 was completed by all participants (VHI-10). Physical (pVHI), emotional (eVHI) and functional (fVHI) subscores were calculated. Clinical data were collected (disease stage, CT grade, neutrophil/lymphocyte ratio, CRP, and symptoms).Results: A statistically significant difference between patient and control groups in VHI-10 and CAPE-V scores was detected (p < 0.001). Except eVHI, total score and all subscale scores were higher in patients with COVID-19 as the pVHI was the most affected (η2 = 0.324) subscale. All scores of CAPE-V were significantly worse in patients with COVID-19 as highest impact of COVID-19 was on breathiness (η2 = 0.518). Pre-existing pulmonary comorbidity, dyspnoea and N/L was significantly associated with the VHI-10 overall score (βpc = 4.27, βdyspnoea = 5.69 and βnl = 0.25). The overall severity of CAPE-V was significantly dependent on dyspnoea and pulmonary comorbidity (βdyspnoea = 11.25, βpc = 10.12). VHI ≥4 and CAPE-V overall severity ≥11 were good indicators of COVID-19 related dysphonia.Conclusions: COVID-19 causes patient-reported voice handicap and deteriorates auditory-perceptual measures of voice. COVID-19 related voice impairment was mainly associated with the decreased respiratory capacity.\",\"PeriodicalId\":49903,\"journal\":{\"name\":\"Logopedics Phoniatrics Vocology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Logopedics Phoniatrics Vocology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/14015439.2021.2011958\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Logopedics Phoniatrics Vocology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14015439.2021.2011958","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY","Score":null,"Total":0}

引用次数: 8

摘要

目的:本研究的目的是比较健康个体和COVID-19患者报告的语音障碍和声音听觉感知测量，并探讨临床因素对语音质量的影响。方法:纳入新冠肺炎患者138例和健康对照90例。声音的共识听觉感知评估(CAPE-V)用于根据声音样本的总体严重程度，粗糙度，呼吸，张力，音高和响度对其进行评分。所有参与者完成声音障碍指数-10 (VHI-10)。计算身体(pVHI)、情绪(eVHI)和功能(fVHI)评分。收集临床资料(疾病分期、CT分级、中性粒细胞/淋巴细胞比值、CRP和症状)。结果:患者与对照组在VHI-10和CAPE-V评分亚量表上差异有统计学意义(p 2 = 0.324)。COVID-19患者的所有CAPE-V评分均显著差，其中对呼吸的影响最大(η2 = 0.518)。先前存在的肺部合并症、呼吸困难和N/L与VHI-10总分显著相关(βpc = 4.27， β呼吸困难= 5.69，βnl = 0.25)。CAPE-V的总体严重程度显著依赖于呼吸困难和肺部合并症(β呼吸困难= 11.25，βpc = 10.12)。VHI≥4和CAPE-V总体严重程度≥11是COVID-19相关语音障碍的良好指标。结论:COVID-19导致患者报告的声音障碍，并使声音的听觉感知指标恶化。与COVID-19相关的声音障碍主要与呼吸能力下降有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Patient reported voice handicap and auditory-perceptual voice assessment outcomes in patients with COVID-19.

Purpose: The purpose of this study is to compare patient-reported voice handicap and auditory-perceptual measures of voice between healthy individuals and COVID-19 patients, as well as to investigate the effect of clinical factors on voice quality.

Methods: COVID-19 patients (n = 138) and 90 healthy controls were included in the study. The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) was used to grade voice samples based on overall severity, roughness, breathiness, strain, pitch, and loudness. The Voice Handicap Index-10 was completed by all participants (VHI-10). Physical (pVHI), emotional (eVHI) and functional (fVHI) subscores were calculated. Clinical data were collected (disease stage, CT grade, neutrophil/lymphocyte ratio, CRP, and symptoms).

Results: A statistically significant difference between patient and control groups in VHI-10 and CAPE-V scores was detected (p < 0.001). Except eVHI, total score and all subscale scores were higher in patients with COVID-19 as the pVHI was the most affected (η² = 0.324) subscale. All scores of CAPE-V were significantly worse in patients with COVID-19 as highest impact of COVID-19 was on breathiness (η² = 0.518). Pre-existing pulmonary comorbidity_, dyspnoea and N/L was significantly associated with the VHI-10 overall score (β_pc = 4.27, β_dyspnoea = 5.69 and β_nl = 0.25). The overall severity of CAPE-V was significantly dependent on dyspnoea and pulmonary comorbidity (β_dyspnoea = 11.25, β_pc = 10.12). VHI ≥4 and CAPE-V overall severity ≥11 were good indicators of COVID-19 related dysphonia.

Conclusions: COVID-19 causes patient-reported voice handicap and deteriorates auditory-perceptual measures of voice. COVID-19 related voice impairment was mainly associated with the decreased respiratory capacity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Logopedics Phoniatrics Vocology 医学-耳鼻喉科学

CiteScore

2.50

自引率

9.10%

发文量

审稿时长

>12 weeks

期刊介绍： Logopedics Phoniatrics Vocology is an amalgamation of the former journals Scandinavian Journal of Logopedics & Phoniatrics and VOICE. The intention is to cover topics related to speech, language and voice pathology as well as normal voice function in its different aspects. The Journal covers a wide range of topics, including: Phonation and laryngeal physiology Speech and language development Voice disorders Clinical measurements of speech, language and voice Professional voice including singing Bilingualism Cleft lip and palate Dyslexia Fluency disorders Neurolinguistics and psycholinguistics Aphasia Motor speech disorders Voice rehabilitation of laryngectomees Augmentative and alternative communication Acoustics Dysphagia Publications may have the form of original articles, i.e. theoretical or methodological studies or empirical reports, of reviews of books and dissertations, as well as of short reports, of minor or ongoing studies or short notes, commenting on earlier published material. Submitted papers will be evaluated by referees with relevant expertise.